A tandem-locked fluorescent NETosis reporter for the prognosis assessment of cancer immunotherapy

NETosis, the peculiar type of neutrophil death, plays important roles in pro-tumorigenic functions and inhibits cancer immunotherapy. Non-invasive real-time imaging is thus imperative for prognosis of cancer immunotherapy yet remains challenging. Herein, we report a Tandem-locked NETosis Reporter 1...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Cheng, Penghui, He, Shasha, Zhang, Chi, Liu, Jing, Pu, Kanyi
অন্যান্য লেখক: School of Chemistry, Chemical Engineering and Biotechnology
বিন্যাস: Journal Article
ভাষা:English
প্রকাশিত: 2023
বিষয়গুলি:
অনলাইন ব্যবহার করুন:https://hdl.handle.net/10356/170296
_version_ 1826120675122741248
author Cheng, Penghui
He, Shasha
Zhang, Chi
Liu, Jing
Pu, Kanyi
author2 School of Chemistry, Chemical Engineering and Biotechnology
author_facet School of Chemistry, Chemical Engineering and Biotechnology
Cheng, Penghui
He, Shasha
Zhang, Chi
Liu, Jing
Pu, Kanyi
author_sort Cheng, Penghui
collection NTU
description NETosis, the peculiar type of neutrophil death, plays important roles in pro-tumorigenic functions and inhibits cancer immunotherapy. Non-invasive real-time imaging is thus imperative for prognosis of cancer immunotherapy yet remains challenging. Herein, we report a Tandem-locked NETosis Reporter 1 (TNR1 ) that activates fluorescence signals only in the presence of both neutrophil elastase (NE) and cathepsin G (CTSG) for the specific imaging of NETosis. In the aspect of molecular design, the sequence of biomarker-specific tandem peptide blocks can largely affect the detection specificity towards NETosis. In live cell imaging, the tandem-locked design allows TNR1 to differentiate NETosis from neutrophil activation, while single-locked reporters fail to do so. The near-infrared signals from activated TNR1 in tumor from living mice were consistent with the intratumoral NETosis levels from histological results. Moreover, the near-infrared signals from activated TNR1 negatively correlated with tumor inhibition effect after immunotherapy, thereby providing prognosis for cancer immunotherapy. Thus, our study not only demonstrates the first sensitive optical reporter for noninvasive monitoring of NETosis levels and evaluation of cancer immunotherapeutic efficacy in tumor-bearing living mice, but also proposes a generic approach for tandem-locked probe design.
first_indexed 2024-10-01T05:20:20Z
format Journal Article
id ntu-10356/170296
institution Nanyang Technological University
language English
last_indexed 2024-10-01T05:20:20Z
publishDate 2023
record_format dspace
spelling ntu-10356/1702962023-09-06T02:30:20Z A tandem-locked fluorescent NETosis reporter for the prognosis assessment of cancer immunotherapy Cheng, Penghui He, Shasha Zhang, Chi Liu, Jing Pu, Kanyi School of Chemistry, Chemical Engineering and Biotechnology Lee Kong Chian School of Medicine (LKCMedicine) Science::Medicine Molecular Design Neutrophils NETosis, the peculiar type of neutrophil death, plays important roles in pro-tumorigenic functions and inhibits cancer immunotherapy. Non-invasive real-time imaging is thus imperative for prognosis of cancer immunotherapy yet remains challenging. Herein, we report a Tandem-locked NETosis Reporter 1 (TNR1 ) that activates fluorescence signals only in the presence of both neutrophil elastase (NE) and cathepsin G (CTSG) for the specific imaging of NETosis. In the aspect of molecular design, the sequence of biomarker-specific tandem peptide blocks can largely affect the detection specificity towards NETosis. In live cell imaging, the tandem-locked design allows TNR1 to differentiate NETosis from neutrophil activation, while single-locked reporters fail to do so. The near-infrared signals from activated TNR1 in tumor from living mice were consistent with the intratumoral NETosis levels from histological results. Moreover, the near-infrared signals from activated TNR1 negatively correlated with tumor inhibition effect after immunotherapy, thereby providing prognosis for cancer immunotherapy. Thus, our study not only demonstrates the first sensitive optical reporter for noninvasive monitoring of NETosis levels and evaluation of cancer immunotherapeutic efficacy in tumor-bearing living mice, but also proposes a generic approach for tandem-locked probe design. Ministry of Education (MOE) National Research Foundation (NRF) K.P. thanks Singapore National Research Foundation (NRF) (NRF‐NRFI07‐2021‐0005), and Singapore Ministry of Education, Academic Research Fund Tier 1 (2019‐T1‐002‐045, RG125/19, RT05/20), Academic Research Fund Tier 2 (MOE‐T2EP30220‐0010; MOE‐T2EP30221‐0004), for the financial support. 2023-09-06T02:30:20Z 2023-09-06T02:30:20Z 2023 Journal Article Cheng, P., He, S., Zhang, C., Liu, J. & Pu, K. (2023). A tandem-locked fluorescent NETosis reporter for the prognosis assessment of cancer immunotherapy. Angewandte Chemie International Edition, 62(26), e202301625-. https://dx.doi.org/10.1002/anie.202301625 1433-7851 https://hdl.handle.net/10356/170296 10.1002/anie.202301625 37099322 2-s2.0-85159293496 26 62 e202301625 en NRF-NRFI07-2021-0005 2019-T1-002-045 RG125/19 RT05/20 MOE-T2EP30220-0010 MOE-T2EP30221-0004 Angewandte Chemie International Edition © 2023 Wiley-VCH GmbH. All rights reserved.
spellingShingle Science::Medicine
Molecular Design
Neutrophils
Cheng, Penghui
He, Shasha
Zhang, Chi
Liu, Jing
Pu, Kanyi
A tandem-locked fluorescent NETosis reporter for the prognosis assessment of cancer immunotherapy
title A tandem-locked fluorescent NETosis reporter for the prognosis assessment of cancer immunotherapy
title_full A tandem-locked fluorescent NETosis reporter for the prognosis assessment of cancer immunotherapy
title_fullStr A tandem-locked fluorescent NETosis reporter for the prognosis assessment of cancer immunotherapy
title_full_unstemmed A tandem-locked fluorescent NETosis reporter for the prognosis assessment of cancer immunotherapy
title_short A tandem-locked fluorescent NETosis reporter for the prognosis assessment of cancer immunotherapy
title_sort tandem locked fluorescent netosis reporter for the prognosis assessment of cancer immunotherapy
topic Science::Medicine
Molecular Design
Neutrophils
url https://hdl.handle.net/10356/170296
work_keys_str_mv AT chengpenghui atandemlockedfluorescentnetosisreporterfortheprognosisassessmentofcancerimmunotherapy
AT heshasha atandemlockedfluorescentnetosisreporterfortheprognosisassessmentofcancerimmunotherapy
AT zhangchi atandemlockedfluorescentnetosisreporterfortheprognosisassessmentofcancerimmunotherapy
AT liujing atandemlockedfluorescentnetosisreporterfortheprognosisassessmentofcancerimmunotherapy
AT pukanyi atandemlockedfluorescentnetosisreporterfortheprognosisassessmentofcancerimmunotherapy
AT chengpenghui tandemlockedfluorescentnetosisreporterfortheprognosisassessmentofcancerimmunotherapy
AT heshasha tandemlockedfluorescentnetosisreporterfortheprognosisassessmentofcancerimmunotherapy
AT zhangchi tandemlockedfluorescentnetosisreporterfortheprognosisassessmentofcancerimmunotherapy
AT liujing tandemlockedfluorescentnetosisreporterfortheprognosisassessmentofcancerimmunotherapy
AT pukanyi tandemlockedfluorescentnetosisreporterfortheprognosisassessmentofcancerimmunotherapy